Recruiting

Cancer Prevention

Sponsor:

Hackensack Meridian Health

Code:

NCT06804395

Conditions

Cancer Risk

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Study Details

Brief summary:

Early diagnosis of cancer allows for better treatment outcomes, higher survival rates, and lower costs of care. It is shown that cancer monitoring for cancer in at-risk populations is a key component in early diagnosis. The HMH Hennessey Institute for Cancer prevention and Applied Molecular Science (HICAP) is a newly founded institute, providing clinical services for cancer screening and risk assessment to the community, as well as research in cancer risk and prevention. The CanScan registry will prospectively collect data from participants in the form of questionnaires. The registry will also capture data that is collected as per non-research assessments, for participants who consent to participate. The registry will facilitate better understanding of cancer risk, screening, and diagnostics.

Conditions

Cancer Risk

Study ID

NCT06804395

Start date

Oct 1, 2024

Status verified date

May, 2026

Completion date

Oct 1, 2034

Anticipated

Primary completion date

Oct 1, 2034

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

  • Adults ( 18 and older)
  • Ability to provide own consent
  • Must meet at least one of the below criteria, Indicating an increased risk for cancer, any of the following:

  • Family or personal history suggests a familial/hereditary disorder known or suspected of predisposition to cancer.
  • Personal factors associated with an increased risk for cancer include benign breast disease, polyps, tobacco use, etc.as defined by the investigator.
  • Family members of participating individuals.
  • Any participant in the HICAP program regardless of cancer risk

Study Design

Enrollment

10000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Rate of Pathogenic Germline Variants (PGV) [ Time Frame: 10 years from study initiation as defined based on the date the first patient was enrolled. ]

Central Contacts and Locations

Central contacts

Renata Castro, MS

Renata.Castro@hmh.org

Locations

Hennessy Institute for Cancer Prevention and Applied Molecular Medicine

Recruiting

Totowa, New Jersey, United States, 07462

Contacts

More Information

Sponsor

Hackensack Meridian Health

Last update posted

May 26, 2026

Last verified

May, 2026

Keywords

  • Cancer Prevention
  • Cancer Risk
  • Cancer Early Detection
  • Cancer High Risk

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Hackensack Meridian Health on 2026-05-26.